Safe and Effective Treatments Are Needed for Cryptosporidiosis, a Truly Neglected Tropical Disease

Overview

Journal BMJ Glob Health

Specialty Public Health

Date 2023 Aug 4

PMID 37541693

Authors

Ian H Gilbert

Sumiti Vinayak

Boris Striepen

Ujjini H Manjunatha

Ibrahim A Khalil

Wesley C Van Voorhis

Affiliations

Soon will be listed here.

Citing Articles

Deciphering Transcription in : Polycistronic Gene Expression and Chromatin Accessibility.

Xiao R, Baptista R, Agyabeng-Dadzie F, Li Y, Dong Y, Schmitz R bioRxiv. 2025; .

PMID: 39868316 PMC: 11761812. DOI: 10.1101/2025.01.17.633476.

A new chromosome-level genome assembly and annotation of Cryptosporidium meleagridis.

Penumarthi L, Baptista R, Beaudry M, Glenn T, Kissinger J Sci Data. 2024; 11(1):1388.

PMID: 39695163 PMC: 11655656. DOI: 10.1038/s41597-024-04235-7.

Cryptosporidiosis in a Zoonotic Gastrointestinal Disorder Perspective: Present Status, Risk Factors, Pathophysiology, and Treatment, Particularly in Immunocompromised Patients.

Balendran T, Iddawela D, Lenadora S J Trop Med. 2024; 2024:6439375.

PMID: 39534184 PMC: 11557182. DOI: 10.1155/2024/6439375.

Characterization of NFDQ1 in Cryptosporidium parvum.

Ao Y, Gong X, Li J, Zhao R, Song S, Guo Y Parasit Vectors. 2024; 17(1):439.

PMID: 39462401 PMC: 11514877. DOI: 10.1186/s13071-024-06532-x.

lysyl-tRNA synthetase inhibitors define the interplay between solubility and permeability required to achieve efficacy.

Caldwell N, Peet C, Miller P, Colon B, Taylor M, Cocco M Sci Transl Med. 2024; 16(770):eadm8631.

PMID: 39441903 PMC: 7617456. DOI: 10.1126/scitranslmed.adm8631.

References

Opintan J, Newman M, Ayeh-Kumi P, Affrim R, Gepi-Attee R, Sevilleja J . Pediatric diarrhea in southern Ghana: etiology and association with intestinal inflammation and malnutrition. Am J Trop Med Hyg. 2010; 83(4):936-43. PMC: 2946773. DOI: 10.4269/ajtmh.2010.09-0792. View

Arnold S, Choi R, Hulverson M, Schaefer D, Vinayak S, Vidadala R . Necessity of Bumped Kinase Inhibitor Gastrointestinal Exposure in Treating Cryptosporidium Infection. J Infect Dis. 2017; 216(1):55-63. PMC: 5853285. DOI: 10.1093/infdis/jix247. View

Ashigbie P, Shepherd S, Steiner K, Amadi B, Aziz N, Manjunatha U . Use-case scenarios for an anti-Cryptosporidium therapeutic. PLoS Negl Trop Dis. 2021; 15(3):e0009057. PMC: 7951839. DOI: 10.1371/journal.pntd.0009057. View

Chappell C, Okhuysen P, Langer-Curry R, Widmer G, Akiyoshi D, Tanriverdi S . Cryptosporidium hominis: experimental challenge of healthy adults. Am J Trop Med Hyg. 2006; 75(5):851-7. View

Love M, Choy R . Emerging treatment options for cryptosporidiosis. Curr Opin Infect Dis. 2021; 34(5):455-462. PMC: 7611666. DOI: 10.1097/QCO.0000000000000761. View

Korpe P, Valencia C, Haque R, Mahfuz M, McGrath M, Houpt E . Epidemiology and Risk Factors for Cryptosporidiosis in Children From 8 Low-income Sites: Results From the MAL-ED Study. Clin Infect Dis. 2018; 67(11):1660-1669. PMC: 6233690. DOI: 10.1093/cid/ciy355. View

Jumani R, Hasan M, Stebbins E, Donnelly L, Miller P, Klopfer C . A suite of phenotypic assays to ensure pipeline diversity when prioritizing drug-like Cryptosporidium growth inhibitors. Nat Commun. 2019; 10(1):1862. PMC: 6478823. DOI: 10.1038/s41467-019-09880-w. View

Hulverson M, Choi R, Arnold S, Schaefer D, Hemphill A, McCloskey M . Advances in bumped kinase inhibitors for human and animal therapy for cryptosporidiosis. Int J Parasitol. 2017; 47(12):753-763. PMC: 5772984. DOI: 10.1016/j.ijpara.2017.08.006. View

Oboh E, Schubert T, Teixeira J, Stebbins E, Miller P, Philo E . Optimization of the Urea Linker of Triazolopyridazine MMV665917 Results in a New Anticryptosporidial Lead with Improved Potency and Predicted hERG Safety Margin. J Med Chem. 2021; 64(15):11729-11745. PMC: 8792998. DOI: 10.1021/acs.jmedchem.1c01136. View

10.

Swale C, Bougdour A, Gnahoui-David A, Tottey J, Georgeault S, Laurent F . Metal-captured inhibition of pre-mRNA processing activity by CPSF3 controls infection. Sci Transl Med. 2019; 11(517). DOI: 10.1126/scitranslmed.aax7161. View

11.

McCarthy J, Ruckle T, Djeriou E, Cantalloube C, Ter-Minassian D, Baker M . A Phase II pilot trial to evaluate safety and efficacy of ferroquine against early Plasmodium falciparum in an induced blood-stage malaria infection study. Malar J. 2016; 15:469. PMC: 5022189. DOI: 10.1186/s12936-016-1511-3. View

12.

Amadi B, Mwiya M, Sianongo S, Payne L, Watuka A, Katubulushi M . High dose prolonged treatment with nitazoxanide is not effective for cryptosporidiosis in HIV positive Zambian children: a randomised controlled trial. BMC Infect Dis. 2009; 9:195. PMC: 2794874. DOI: 10.1186/1471-2334-9-195. View

13.

Baragana B, Forte B, Choi R, Hewitt S, Bueren-Calabuig J, Pisco J . Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosis. Proc Natl Acad Sci U S A. 2019; 116(14):7015-7020. PMC: 6452685. DOI: 10.1073/pnas.1814685116. View

14.

Jumani R, Blais J, Tillmann H, Segal F, Wetty D, Ostermeier C . Opportunities and Challenges in Developing a Controlled Human Infection Model for Testing Antiparasitic Agents. ACS Infect Dis. 2021; 7(5):959-968. PMC: 8154424. DOI: 10.1021/acsinfecdis.1c00057. View

15.

Wang Z, Liu Q, Liu H, Li S, Zhang L, Zhao Y . Prevalence of Cryptosporidium, microsporidia and Isospora infection in HIV-infected people: a global systematic review and meta-analysis. Parasit Vectors. 2018; 11(1):28. PMC: 5759777. DOI: 10.1186/s13071-017-2558-x. View

16.

Wanyiri J, Kanyi H, Maina S, Wang D, Steen A, Ngugi P . Cryptosporidiosis in HIV/AIDS patients in Kenya: clinical features, epidemiology, molecular characterization and antibody responses. Am J Trop Med Hyg. 2014; 91(2):319-28. PMC: 4125256. DOI: 10.4269/ajtmh.13-0254. View

17.

Chappell C, Okhuysen P, Sterling C, Wang C, Jakubowski W, DuPont H . Infectivity of Cryptosporidium parvum in healthy adults with pre-existing anti-C. parvum serum immunoglobulin G. Am J Trop Med Hyg. 1999; 60(1):157-64. DOI: 10.4269/ajtmh.1999.60.157. View

18.

Checkley W, White Jr A, Jaganath D, Arrowood M, Chalmers R, Chen X . A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium. Lancet Infect Dis. 2014; 15(1):85-94. PMC: 4401121. DOI: 10.1016/S1473-3099(14)70772-8. View

19.

Hulverson M, Vinayak S, Choi R, Schaefer D, Castellanos-Gonzalez A, Vidadala R . Bumped-Kinase Inhibitors for Cryptosporidiosis Therapy. J Infect Dis. 2017; 215(8):1275-1284. PMC: 5853794. DOI: 10.1093/infdis/jix120. View

20.

Hulverson M, Choi R, McCloskey M, Whitman G, Ojo K, Michaels S . Repurposing Infectious Disease Hits as Anti- Leads. ACS Infect Dis. 2021; 7(5):1275-1282. DOI: 10.1021/acsinfecdis.1c00076. View